FDA approves angiotensin II for distributive shock

The FDA approved angiotensin-II (Giapreza) as a new intravenous vasopressor for septic shock and other forms of distributive shock. The first new FDA-approved vasopressor in decades.
This is based on recent trial, which was discussed here.


Artificial Intelligence as good as radiologists in detecting Lung Infection in Supine Chest Radiographs of Critically Ill PatientsRead more
%d bloggers like this: